Eli Lilly & Co (LLY): Long-Term Debt
$29.47B
As of 2024-12-31
+20.7%
3-year compound annual growth
+16.7%
5-year compound annual growth
| Period ended | Long-Term Debt | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $29.47B | +54.3% | 2025-02-19, Balance as of period end |
| 2023-12-31 | $19.10B | +29.0% | 2025-02-19, Balance as of period end |
| 2022-12-31 | $14.82B | -11.5% | 2024-02-21, Balance as of period end |
| 2021-12-31 | $16.74B | +2.4% | 2023-02-22, Balance as of period end |
| 2020-12-31 | $16.35B | +19.9% | 2022-02-23, Balance as of period end |
| 2019-12-31 | $13.64B | n/a | 2021-02-17, Balance as of period end |
| No annual figure between 2016-12-31 and 2019-12-31. | |||
| 2016-12-31 | $9.01B | +12.9% | 2017-02-21, Balance as of period end |
| 2015-12-31 | $7.98B | n/a | 2017-02-21, Balance as of period end |
| No annual figure between 2013-12-31 and 2015-12-31. | |||
| 2013-12-31 | $5.21B | -5.8% | 2014-02-19, Balance as of period end |
| 2012-12-31 | $5.53B | -20.8% | 2014-02-19, Balance as of period end |
| 2011-12-31 | $6.98B | +2.8% | 2013-02-21, Balance as of period end |
| 2010-12-31 | $6.79B | +2.0% | 2012-02-24, Balance as of period end |
| 2009-12-31 | $6.66B | n/a | 2011-02-22, Balance as of period end |